Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue's has fired CEO Thibaut Mongon, who has also stepped down from the board, the consumer health company said on Monday, ...

Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand ...

Kenvue plans to cut 69 jobs at its Summit HQ as part of global restructuring after splitting from Johnson & Johnson.

The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice.

On June 26, Kenvue, which is more commonly known for some of its brands like Neutrogena, Listerine, Aveeno, and Tylenol, released its second annual Healthy Lives Mission Report.

Investors in Kenvue Inc (Symbol: KVUE) saw new options begin trading today, for the December 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay ...